Gene:
CCL16
chemokine (C-C motif) ligand 16

PharmGKB contains no dosing guidelines for this . To report known genotype-based dosing guidelines, or if you are interested in developing guidelines, click here.

PharmGKB contains no drug labels with pharmacogenomic information for this . To report a drug label with PGx, click here.

Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they are written and are intended only to assist clinicians in decision-making and to identify questions for further research. New evidence may have emerged since the time an annotation was submitted to the PharmGKB. The annotations are limited in scope and are not applicable to interventions or diseases that are not specifically identified.

The annotations do not account for individual variations among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care provider to determine the best course of treatment for a patient. Adherence to any guideline is voluntary, with the ultimate determination regarding its application to be made solely by the clinician and the patient. PharmGKB assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the PharmGKB clinical annotations, or for any errors or omissions.

? = Mouse-over for quick help

This is a non-comprehensive list of genetic tests with pharmacogenetics relevance, typically submitted by the manufacturer and manually curated by PharmGKB. The information listed is provided for educational purposes only and does not constitute an endorsement of any listed test or manufacturer.

A more complete listing of genetic tests is found at the Genetic Testing Registry (GTR).

PGx Test Variants Assayed Related Drugs?

Overview

Alternate Names:  None
Alternate Symbols:  CKb12; HCC-4; LCC-1; LEC; LMC; Mtn-1; NCC-4; SCYL4
PharmGKB Accession Id: PA35547

Details

Cytogenetic Location: chr17 : q11.2 - q12
GP mRNA Boundary: chr17 : 34303535 - 34308523
GP Gene Boundary: chr17 : 34300535 - 34318523
Strand: minus
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

PharmGKB Curated Pathways

Pathways created internally by PharmGKB based primarily on literature evidence.

PharmGKB contains no curated pathways for this gene. If you would like to volunteer to work on a pathway, please let us know.

External Pathways

Links to non-PharmGKB pathways.

  1. Chemokine receptors bind chemokines - (Reactome via Pathway Interaction Database)

LinkOuts

Entrez Gene:
6360
OMIM:
601394
UCSC Genome Browser:
NM_004590
RefSeq RNA:
NM_004590
RefSeq Protein:
NP_004581
RefSeq DNA:
AC_000060
AC_000149
NC_000017
NT_010799
NW_001838432
NW_926772
UniProtKB:
CCL16_HUMAN (O15467)
Ensembl:
ENSG00000161573
GenAtlas:
CCL16
GeneCard:
CCL16
MutDB:
CCL16
ALFRED:
LO054331Q
HuGE:
CCL16
Comparative Toxicogenomics Database:
6360
ModBase:
O15467
HumanCyc Gene:
HS08596
HGNC:
10614

Common Searches